Cargando…
Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design
BACKGROUND: Pulmonary arterial hypertension (PAH) is a progressive disease characterized by high mean pulmonary arterial pressure (≥ 20 mmHg) and remodeling of the vascular arteries. Approved therapies improve symptoms and delay clinical worsening in the long term, but they do not relieve acute exer...
Autores principales: | Benza, Raymond L., Franco, Veronica, Aras, Mandar A., Spikes, Leslie, Grinnan, Daniel, Satler, Carol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758858/ https://www.ncbi.nlm.nih.gov/pubmed/36527025 http://dx.doi.org/10.1186/s12931-022-02262-9 |
Ejemplares similares
-
Safety, Tolerability, and Pharmacokinetics of RT234 (Vardenafil Inhalation Powder): A First-in-Human, Ascending Single- and Multiple-Dose Study in Healthy Subjects
por: Eldon, Michael A., et al.
Publicado: (2021) -
Isolation and identification of a novel vardenafil analogue, propoxy-vardenafil, found as an adulterant in a health supplement
por: Sun, Jian, et al.
Publicado: (2023) -
Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence
por: Morales, Antonio Martín, et al.
Publicado: (2009) -
Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib
por: Bourne, Michael H., et al.
Publicado: (2021) -
Vardenafil como tratamiento en la disfunción eréctil : revisión bibliográfica
por: Rasgado Díaz, Fernando
Publicado: (2006)